Addus HomeCare Corporation (NASDAQ: ADUS) is making waves in the healthcare sector, particularly within the Medical Care Facilities industry. With a market cap of $2.19 billion, Addus is a notable..
Veracyte, Inc. (NASDAQ: VCYT), a key player in the diagnostics and research industry, is garnering attention from investors with its promising growth potential and a notable 12.76% upside based on..
Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, is capturing investor attention with a compelling potential upside of 76.07% based on its current price and analyst..
PTC Therapeutics, Inc. (PTCT), a pioneering player in the biotechnology sector, is known for its dedicated focus on the discovery, development, and commercialization of treatments for rare disorders. Headquartered in..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, continues to capture investor attention with its robust focus on central nervous system (CNS) disorders and rare diseases...
Metsera, Inc. (MTSR) is a burgeoning player in the healthcare sector, specifically within the biotechnology industry. Established in 2022 and headquartered in New York, this clinical-stage company is at the..
LivaNova PLC (NASDAQ: LIVN) is emerging as a company of interest for investors in the healthcare sector, particularly in the medical devices industry. Based in the United Kingdom, LivaNova specializes..
Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector focusing on over-the-counter solutions, is capturing the attention of investors with a notable potential upside of 58.3%. Headquartered..
Privia Health Group, Inc. (NASDAQ: PRVA) is capturing investors’ attention with its robust growth trajectory, particularly highlighted by a potential upside of 22.51% based on the average analyst target price..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $2.5 billion, this..
CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology sector with its groundbreaking CRISPR/Cas9 gene-editing platform, poised to transform the treatment landscape for several serious human diseases...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a notable player in the biotechnology sector, has captured investor attention with its focus on developing innovative therapies for rare and ultra-rare genetic diseases. Headquartered..
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving out a niche in the medical devices sector, specifically within the transformative space of surgical robotics for urology. Headquartered in San Jose, California,..
ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers a fascinating investment opportunity characterized by a compelling 42.3%..
Investors eyeing the biotechnology sector should consider Avidity Biosciences, Inc. (NASDAQ: RNA), a trailblazer in RNA therapeutics with a market capitalization of $10.26 billion. This San Diego-based company stands at..
Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, is capturing investor attention with a significant potential upside of 35.69% based on its average target price. Specializing in..
Option Care Health, Inc. (NASDAQ: OPCH), a key player in the healthcare sector, specifically within the medical care facilities industry, is currently capturing the attention of investors with its promising..
Telix Pharmaceuticals Limited (ASX: TLX) is garnering significant attention from investors due to its robust growth prospects and a near-doubling potential upside, as indicated by recent analyst ratings. Operating within..
As the healthcare sector continues to draw investor attention, Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out with its promising potential upside of 32.29%. With a market capitalization of $2.98..
